Følg
Morten Lock Hansen
Morten Lock Hansen
Department of Cardiology, Gentofte University Hospital, Denmark
Verificeret mail på regionh.dk
Titel
Citeret af
Citeret af
År
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European …
Authors/Task Force Members, SV Konstantinides, A Torbicki, G Agnelli, ...
European heart journal 35 (43), 3033-3080, 2014
42332014
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
CTP Morten L Hansen 1, Rikke Sørensen, Mette T Clausen, Marie Louise Fog ...
Arch Intern Med, 2010
3632*2010
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million …
TK Schramm, GH Gislason, L Køber, S Rasmussen, JN Rasmussen, ...
Circulation 117 (15), 1945-1954, 2008
6712008
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: a nationwide cohort study
JB Olesen, C Torp-Pedersen, ML Hansen, GYH Lip
Thrombosis and haemostasis 107 (06), 1172-1179, 2012
6432012
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’nationwide cohort study
JB Olesen, GYH Lip, J Lindhardsen, DA Lane, O Ahlehoff, ML Hansen, ...
Thrombosis and haemostasis 106 (10), 739-749, 2011
6122011
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction …
TK Schramm, GH Gislason, A Vaag, JN Rasmussen, F Folke, ML Hansen, ...
European heart journal 32 (15), 1900-1908, 2011
6012011
Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure
GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ...
Archives of internal medicine 169 (2), 141-149, 2009
3732009
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
C Selmer, JB Olesen, ML Hansen, J Lindhardsen, AMS Olsen, ...
Bmj 345, 2012
3522012
Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study
C Selmer, JB Olesen, ML Hansen, LM von Kappelgaard, JC Madsen, ...
The Journal of Clinical Endocrinology & Metabolism 99 (7), 2372-2382, 2014
3362014
Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study
AN Bonde, GYH Lip, AL Kamper, PR Hansen, M Lamberts, K Hommel, ...
Journal of the American College of Cardiology 64 (23), 2471-2482, 2014
3322014
Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study
M Lamberts, GH Gislason, GYH Lip, JF Lassen, JB Olesen, AP Mikkelsen, ...
Circulation 129 (15), 1577-1585, 2014
3082014
Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations
F Folke, FK Lippert, SL Nielsen, GH Gislason, ML Hansen, TK Schramm, ...
Circulation 120 (6), 510-517, 2009
2602009
Bleeding risk in ‘real world’patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
JB Olesen, GYH Lip, PR Hansen, J Lindhardsen, O Ahlehoff, ...
Journal of Thrombosis and Haemostasis 9 (8), 1460-1467, 2011
2482011
Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes
GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ...
Circulation 116 (7), 737-744, 2007
2352007
Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
R Sørensen, G Gislason, C Torp-Pedersen, JB Olesen, EL Fosbøl, ...
BMJ open 3 (5), e002758, 2013
2292013
Risk of myocardial infarction and death associated with the use of nonsteroidal anti‐inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study
EL Fosbøl, GH Gislason, S Jacobsen, F Folke, ML Hansen, TK Schramm, ...
Clinical Pharmacology & Therapeutics 85 (2), 190-197, 2009
2212009
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011–2013
JB Olesen, R Sørensen, ML Hansen, M Lamberts, P Weeke, ...
EP Europace 17 (2), 187-193, 2014
2072014
Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction
AMS Olsen, GH Gislason, P McGettigan, E Fosbøl, R Sørensen, ...
Jama 313 (8), 805-814, 2015
1932015
Differences between out-of-hospital cardiac arrest in residential and public locations and implications for public-access defibrillation
F Folke, GH Gislason, FK Lippert, SL Nielsen, P Weeke, ML Hansen, ...
Circulation 122 (6), 623-630, 2010
1832010
Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy
ML Hansen, RMHG Jepsen, JB Olesen, MH Ruwald, D Karasoy, ...
EP Europace 17 (1), 18-23, 2015
1702015
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20